- Latest available (Revised)
- Original (As adopted by EU)
Commission Directive 2004/33/EC of 22 March 2004 implementing Directive 2002/98/EC of the European Parliament and of the Council as regards certain technical requirements for blood and blood components (Text with EEA relevance)
After exit day there will be three versions of this legislation to consult for different purposes. The legislation.gov.uk version is the version that applies in the UK. The EU Version currently on EUR-lex is the version that currently applies in the EU i.e you may need this if you operate a business in the EU.
The web archive version is the official version of this legislation item as it stood on exit day before being published to legislation.gov.uk and any subsequent UK changes and effects applied. The web archive also captured associated case law and other language formats from EUR-Lex.
EU Directives are being published on this site to aid cross referencing from UK legislation. After IP completion day (31 December 2020 11pm) no further amendments will be applied to this version.
Article 5.Storage, transport and distribution conditions for blood and blood components
Article 6.Quality and safety requirements for blood and blood components
1. ‘Autologous donation’ means blood and blood components collected from an...
2. ‘Allogeneic donation’ means blood and blood components collected from an...
3. ‘Validation’ means the establishment of documented and objective evidence that...
5. ‘Cryopreservation’ means prolongation of the storage life of blood components...
6. ‘Plasma’ means the liquid portion of the blood in which...
7. ‘Cryoprecipitate’ means a plasma component prepared from plasma, fresh-frozen, by...
8. ‘Washed’ means a process of removing plasma or storage medium...
10. ‘Red cells, buffy coat removed’ means the red cells from...
11. ‘Red cells, leucocyte-depleted’ means the red cells from a single...
12. ‘Red cells in additive solution’ means the red cells from...
13. ‘Additive solution’ means a solution specifically formulated to maintain beneficial...
14. ‘Red cells, buffy coat removed, in additive solution’ means the...
15. ‘Buffy coat’ means a blood component prepared by centrifugation of...
16. ‘Red cells, leucocyte-depleted, in additive solution’ means the red cells...
17. ‘Red cells, apheresis’ means the red cells from an apheresis...
18. ‘Apheresis’ means a method of obtaining one or more blood...
19. ‘Platelets, apheresis’ means a concentrated suspension of blood platelets obtained...
21. ‘Platelets, recovered, pooled’ means a concentrated suspension of blood platelets,...
22. ‘Platelets, recovered, pooled, leucocyte-depleted’ means a concentrated suspension of blood...
23. ‘Platelets, recovered, single unit’ means a concentrated suspension of blood...
24. ‘Platelets, recovered, single unit, leucocyte-depleted’ means a concentrated suspension of...
25. ‘Plasma, fresh-frozen’ means the supernatant plasma separated from a whole...
26. ‘Plasma, cryoprecipitate-depleted for transfusion’ means a plasma component prepared from...
27. ‘Granulocytes, apheresis’ means a concentrated suspension of granulocytes obtained by...
28. ‘Statistical process control’ means a method of quality control of...
PART A Information to be provided to prospective donors of blood or blood components
1. Accurate educational materials, which are understandable for members of the...
2. For both allogeneic and autologous donations, the reasons for requiring...
3. Information on the protection of personal data: no unauthorised disclosure...
4. The reasons why individuals are not to make donations which...
5. Specific information on the nature of the procedures involved either...
6. Information on the option for donors to change their mind...
7. The reasons why it is important that donors inform the...
8. Information on the responsibility of the blood establishment to inform...
9. Information why unused autologous blood and blood components will be...
10. Information that test results detecting markers for viruses, such as...
11. Information on the opportunity for donors to ask questions at...
PART B Information to be obtained from donors by blood establishments at every donation
ELIGIBILITY CRITERIA FOR DONORS OF WHOLE BLOOD AND BLOOD COMPONENTS
STORAGE, TRANSPORT AND DISTRIBUTION CONDITIONS FOR BLOOD AND BLOOD COMPONENTS
QUALITY AND SAFETY REQUIREMENTS FOR BLOOD AND BLOOD COMPONENTS
2. QUALITY CONTROL REQUIREMENTS FOR BLOOD AND BLOOD COMPONENTS
2.1. Blood and blood components must comply with the following technical...
2.2. Appropriate bacteriological control of the collection and manufacturing process must...
2.3. Member States must take all necessary measures to ensure that...
2.4. For autologous donations, the measures marked with an asterisk (*)...
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As adopted by EU): The original version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
This timeline shows the different versions taken from EUR-Lex before exit day and during the implementation period as well as any subsequent versions created after the implementation period as a result of changes made by UK legislation.
The dates for the EU versions are taken from the document dates on EUR-Lex and may not always coincide with when the changes came into force for the document.
For any versions created after the implementation period as a result of changes made by UK legislation the date will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. For further information see our guide to revised legislation on Understanding Legislation.
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: